Senior Research Scientist – Translational Pharmacology
ElancoSenior Research Scientist – Translational Pharmacology
ElancoLocation
Indianapolis, IN
Type
Full-time
Posted
11/15/2026
Compensation
Not listed
Job description
The (Senior) Research Scientist role at Elanco focuses on driving pharmacological strategies in early drug development for both chemical and biological entities. This position is part of the Non-Clinical Development team, emphasizing the mitigation of clinical development risks. The role involves collaborating with cross-functional teams to translate pharmacological insights into clinical scenarios. The ideal candidate will leverage their expertise to advance pipeline assets and contribute to innovative solutions in animal health.
Requirements
- DVM or PhD in Veterinary Medicine, Medicine, Biology, Biochemistry, or a related field.
- 1–3 years of early-career professional experience in pharmaceutical industry research and/or development.
- Demonstrated expertise in In Vivo pharmacology study design.
- Strong intercultural and interpersonal skills.
Responsibilities
- Design and coordinate translational pharmacological studies for profiling compounds.
- Analyze drug mechanisms of action and disease pathophysiology to generate actionable insights.
- Manage the integration of translational R&D by coordinating early in vivo profiling programs.
- Define and implement biomarker strategies for target engagement and pharmacodynamics.
- Execute reverse translational processes by performing meta-analyses of clinical data across species.
- Serve as the translational pharmacology subject matter expert within a complex matrix organization.
Benefits
- Employees at Elanco are often offered competitive compensation with annual bonus and equity eligibility, retirement plans (including a U.S. 401(k)), and comprehensive health coverage—medical, dental, vision, company-paid life and disability—and even pet insurance. Time-off and flexibility typically include generous PTO, U.S. mid-year and year-end paid shutdown weeks, parental leave, and flexible/remote work options. Employees also benefit from strong development programs (onboarding, course libraries, mentorship, nine ERGs, and tiered leadership programs) that support both professional growth and community involvement.
H-1B filing history
Public USCIS petition and DOL LCA counts · latest USCIS FY2026, LCA FY2026
Combined across 2 filing entities: Elanco Us Inc, Elanco Animal Health Inc
As of Aug 23, 2026
Initial approvals
4
FY2026
Approval rate
100.0%
FY2026
LCA certified
12
FY2026
Entry-level share
0.0%
FY2026
Initial approvals YoY
+3%
Trend
LCA certified YoY
-25%
Trend
Initial approvals by fiscal year
Approval rate by fiscal year
Continuing vs initial approvals
LCA certified positions by quarter
LCA certified positions by fiscal year
Based on public USCIS and DOL filings; not a sponsorship guarantee.
Is this posting expired or inaccurate?
